# Amphetamine-Enhanced Stroke Recovery

> **NCT01905371** · PHASE2 · COMPLETED · sponsor: **Duke University** · enrollment: 99 (actual)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** Dextroamphetamine
- **OTHER:** Physical Therapy
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01905371
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-04
- **Primary completion:** 2007-06
- **Final completion:** 2007-06
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2013-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01905371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01905371, "Amphetamine-Enhanced Stroke Recovery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01905371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*